{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:11:39Z","timestamp":1790683899967,"version":"4.1.0"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Calmodulinopathy is a rare\n                      <jats:italic>CALM<\/jats:italic>\n                      -related hereditary channelopathy presenting with long QT syndrome (LQTS), less commonly with catecholaminergic polymorphic ventricular tachycardia (CPVT) or LQTS\/CPVT overlap. It carries high mortality and limited data from Chinese population.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We reviewed two Chinese children with\n                      <jats:italic>CALM2<\/jats:italic>\n                      mutation-related LQTS\/CPVT overlap. Clinical data, genetic findings, and treatments were collected; outcomes were obtained via telephone follow-up. A systematic literature review was also performed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Case 1 was a 13-year-old girl with seven exercise-induced syncopal episodes. Sinus rhythm QTc 0.55\u2005s, with bidirectional\/polymorphic premature ventricular contractions, and ventricular tachycardia during exercise. A\n                      <jats:italic>de novo CALM2<\/jats:italic>\n                      p.E140Q mutation was found. She remained event-free on propranolol and propafenone for two years. Case 2 was a 15-year-old boy with onset at 4 years. He experienced &amp;gt; 10 syncopal episodes triggered by recurrent exercise or emotional stress. Initial Holter monitoring revealed sinus bradycardia with a mean heart rate of 70 bpm and a maximum QTc of 0.51 s. A\n                      <jats:italic>de novo CALM2<\/jats:italic>\n                      p.N98S mutation was found. Despite treatment with propranolol plus mexiletine, syncopal episodes continued, with the QTc interval further prolonged to 0.62\u2005s. The p.E140Q variant is novel, whereas p.N98S has been previously reported. Literature suggests that \u03b2-blockers combined with Class Ic drugs may be more effective, and implantable cardioverter defibrillator (ICD) implantation should be considered in cases who respond poorly to medical therapy or survivors of aborted cardiac arrest. Patients who experience recurrent syncope coexisting with significant sinus bradycardia may have more severe phenotypes with higher risk of malignant arrhythmias, warranting earlier or more aggressive evaluation for device therapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Genetic testing is recommended for suspected pediatric channelopathies with phenotype-guided individualized treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fped.2026.1902628","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:53:06Z","timestamp":1784699586000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Case Report: Overlap of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia in two Chinese children with CALM2-related calmodulinopathy"],"prefix":"10.3389","volume":"14","author":[{"given":"Jinzhi","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Medical Center, Peking University First Hospital","place":["Beijing, China"]},{"name":"Department of Pediatrics, Kaili First People\u2019s Hospital","place":["Kaili, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianguang","family":"Qi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Medical Center, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Children\u2019s Medical Center, Peking University First Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2165278","DOI":"10.1080\/19336950.2023.2165278","article-title":"Calmodulin mutations in human disease","volume":"17","author":"Hussey","year":"2023","journal-title":"Channels (Austin)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ajhg.2012.08.015","article-title":"Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death","volume":"91","author":"Nyegaard","year":"2012","journal-title":"Am J Hum Genet"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1093\/eurheartj\/ehz311","article-title":"Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the international calmodulinopathy registry","volume":"40","author":"Crotti","year":"2019","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1093\/eurheartj\/ehad418","article-title":"Clinical presentation of calmodulin mutations: the international calmodulinopathy registry","volume":"44","author":"Crotti","year":"2023","journal-title":"Eur Heart J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.3390\/biomedicines14030662","article-title":"Structural and functional regulation of RyR2 in cardiac calcium handling and arrhythmogenesis","volume":"14","author":"Gao","year":"2026","journal-title":"Biomedicines"},{"key":"B6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","article-title":"REVEL: an ensemble method for predicting the pathogenicity of rare missense variants","volume":"99","author":"Ioannidis","year":"2016","journal-title":"Am J Hum Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/cvr\/cvx006","article-title":"Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes","volume":"113","author":"Rocchetti","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/CIRCGENETICS.115.001323","article-title":"Spectrum and prevalence of CALM1-, CALM2-, and CALM3-encoded calmodulin variants in long QT syndrome and functional characterization of a novel long QT syndrome-associated calmodulin missense variant, E141G","volume":"9","author":"Boczek","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e002510","DOI":"10.1161\/CIRCGEN.119.002510","article-title":"Assessment and validation of a phenotype-enhanced variant classification framework to promote or demote RYR2 missense variants of uncertain significance","volume":"12","author":"Giudicessi","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.hrthm.2023.11.030","article-title":"Application and validation of phenotype-enhanced variant classification in east Asian patients with catecholaminergic polymorphic ventricular tachycardia","volume":"21","author":"Hsu","year":"2024","journal-title":"Heart Rhythm"},{"key":"B11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1161\/circgenetics.113.000459","article-title":"Novel calmodulin mutations associated with congenital arrhythmia susceptibility","volume":"7","author":"Makita","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0153851","DOI":"10.1371\/journal.pone.0153851","article-title":"Calmodulin 2 mutation N98S is associated with unexplained cardiac arrest in infants due to low clinical penetrance electrical disorders","volume":"11","author":"Jim\u00e9nez-J\u00e1imez","year":"2016","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1111\/ped.13959","article-title":"Long QT syndrome with a de novo CALM2 mutation in a 4-year-old boy","volume":"61","author":"Fujita","year":"2019","journal-title":"Pediatr Int"},{"key":"B14","doi-asserted-by":"publisher","first-page":"ytab393","DOI":"10.1093\/ehjcr\/ytab393","article-title":"Challenging indication of cardioverter defibrillator implantation after sudden cardiac arrest in the very young: a case series of catecholaminergic polymorphic ventricular tachycardia secondary to de novo calmodulin p.Asn98Ser","volume":"5","author":"Maltret","year":"2021","journal-title":"Eur Heart J Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1253\/circj.CJ-23-0195","article-title":"Calmodulinopathy in Japanese children - their cardiac phenotypes are severe and show early onset in fetal life and infancy","volume":"87","author":"Fukuyama","year":"2023","journal-title":"Circ J"},{"key":"B16","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1017\/S104795112511072X","article-title":"The first case of a Caucasian child with calmodulinopathy related to CALM2 N98S mutation","volume":"36","author":"Buratti","year":"2026","journal-title":"Cardiol Young"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e010891","DOI":"10.1161\/CIRCEP.122.010891","article-title":"Sex and gene influence arrhythmia susceptibility in murine models of calmodulinopathy","volume":"16","author":"Wren","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1161\/CIRCULATIONAHA.120.046450","article-title":"Complex arrhythmia syndrome in a knock-in mouse model carrier of the N98S Calm1 mutation","volume":"142","author":"Tsai","year":"2020","journal-title":"Circulation"},{"key":"B19","doi-asserted-by":"publisher","first-page":"A4140406","DOI":"10.1161\/circ.150.suppl_1.4140406","article-title":"Common misdiagnoses during the workup of inherited channelopathies","volume":"150","author":"Bains","year":"2024","journal-title":"Circulation"},{"key":"B20","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur Heart J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/CIRCEP.110.959916","article-title":"Inhibition of cardiac Ca2+release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia","volume":"4","author":"Hwang","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/CIRCRESAHA.120.316819","article-title":"RYR2 Channel inhibition is the principal mechanism of flecainide action in CPVT","volume":"128","author":"Kryshtal","year":"2021","journal-title":"Circ Res"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.hrthm.2024.04.006","article-title":"An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia","volume":"21","author":"Lamba","year":"2024","journal-title":"Heart Rhythm"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1161\/CIRCULATIONAHA.123.068111","article-title":"Antisense oligonucleotide therapy for calmodulinopathy","volume":"150","author":"Bortolin","year":"2024","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e012036","DOI":"10.1161\/circep.123.012036","article-title":"Single construct suppression and replacement gene therapy for the treatment of all CALM1-, CALM2-, and CALM3-mediated arrhythmia disorders","volume":"17","author":"Hamrick","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1161\/CIRCGEN.119.002581","article-title":"Genetic mosaicism in calmodulinopathy","volume":"12","author":"Wren","year":"2019","journal-title":"Circ Genom Precis Med"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1902628\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T05:53:07Z","timestamp":1784699587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1902628\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":26,"alternative-id":["10.3389\/fped.2026.1902628"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1902628","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1902628"}}